Down's syndrome, cardiac anomalies, and nuchal translucency
نویسندگان
چکیده
منابع مشابه
Nuchal translucency and gestational age.
Professor Wald and his team (Wald et al., 2004) have remodelled the already modelled SURUSS data (Wald et al., 2003a) to claim, firstly, that their results are now similar to those of the multicentre study co-ordinated by the Fetal Medicine Foundation (Snijders et al., 1998), and, secondly, that the gestation of choice for nuchal translucency (NT) measurement is 10 weeks. The latest modelling e...
متن کاملNuchal translucency measurement in first trimester Down syndrome screening.
(1) Approximately three in every four fetuses with Down syndrome have increased nuchal translucency (NT), which is a larger than normal build-up of fluid at the back of the neck. (2) The ultrasound measurement of NT between 11 and 14 weeks' gestation, in combination with the mother's age and the levels of placental biochemical markers in her blood, can be used to detect approximately 84% of fet...
متن کاملDistribution of nuchal translucency in antenatal screening for Down's syndrome
OBJECTIVE To determine whether the standard deviation of nuchal translucency (NT) measurements has decreased over time and if so to revise the estimate and assess the effect of revising the estimate of the standard deviation on the performance of antenatal screening for Down's syndrome. SETTING Data from a routine antenatal screening programme for Down's syndrome comprising 106 affected and 2...
متن کاملNuchal translucency in multiple pregnancies.
AIM To evaluate the prevalence of increased nuchal translucency (NT) in multiple pregnancies and its relation to fetal karyotype and pregnancy outcome. METHODS We measured fetal nuchal translucency (NT) in 6,338 women pregnant from 10+3 to 13+6 weeks by ultrasound and evaluated the prevalence of NT=95th centile in 115 multiple pregnancies, including 100 pairs of twins (70 dichorionic and 30 m...
متن کاملNuchal translucency and lymphatic system maldevelopment.
We describe the histological examination of 18 aborted fetuses that had increased nuchal translucency (NT) between 11(+0) and 13(+6) weeks' gestation. The aim of this study was to assess the corresponding NT anatomic features by immunohistochemical (IHC) investigation. A morphological study was performed using lymphatic and blood endothelial specific markers, as well as smooth muscle actin (SMA...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1999
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.318.7176.70